{"sourcedb":"DevicePMAs@therightstef","sourceid":"P120020_S000","text":"Approval for the supera peripheral stent system.  This device is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (sfa) and/or proximal popliteal artery, with reference vessel diameters of 4.0 to 6.5 mm, and lesion lengths up to 140 mm.","project":"consensus_PMA_Age_Indications"}